Publications by authors named "Mark Slomiany"

Claim this Profile
I
IGF-dependent dynamic modulation of a protease cleavage site in the intrinsically disordered linker domain of human IGFBP2.
Garima Jaipuria, Divya Shet, Shahid Malik, Monalisa Swain, Hanudatta S Atreya, Mark G Slomiany

Proteins· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value Frameworks in Oncology: Comparative Analysis and Implications to the Pharmaceutical Industry.
Mark Slomiany, Priya Madhavan, Michael Kuehn, Sasha Richardson

Am Health Drug Benefits· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug Safety and the Cost of Monitoring: The Role of REMS in Risk Management.
Mark Slomiany, Rema Bitar, Sarah Kruse, Sarah Jeffers, Kenneth Berkowitz

Ther Innov Regul Sci· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population.
Sasha Joseph, Ryan Harrington, Dawn Walter, Judith D Goldberg, Xiaochun Li, Mark Slomiany

Cancer Biomark· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD147-dependent heterogeneity in malignant and chemoresistant properties of cancer cells.
Lu Dai, Maria C Guinea, Mark G Slomiany, Momka Bratoeva, G Daniel Grass

Am J Pathol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-yield bacterial expression and structural characterization of recombinant human insulin-like growth factor binding protein-2.
Monalisa Swain, Mark G Slomiany, Steven A Rosenzweig, Hanudatta S Atreya

Arch Biochem Biophys· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct activation of emmprin and associated pathogenesis by an oncogenic herpesvirus.
Zhiqiang Qin, Lu Dai, Mark G Slomiany, Bryan P Toole, Chris Parsons

Cancer Res· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.
Mark G Slomiany, Lu Dai, Lauren B Tolliver, G Daniel Grass, Yiping Zeng

Clin Cancer Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides.
Mark G Slomiany, Lu Dai, Paul A Bomar, Thomas J Knackstedt, D Alex Kranc

Cancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyaluronan, CD44, and emmprin regulate lactate efflux and membrane localization of monocarboxylate transporters in human breast carcinoma cells.
Mark G Slomiany, G Daniel Grass, Angela D Robertson, Xiao Y Yang, Bernard L Maria

Cancer Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas.
Bernard L Maria, Nalin Gupta, Anne G Gilg, May Abdel-Wahab, Anthony P Leonard, Mark Slomiany

J Child Neurol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells.
Bryan P Toole, Mark G Slomiany

Semin Cancer Biol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.
Bryan P Toole, Mark G Slomiany

Drug Resist Updat· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma.
Mark G Slomiany, Leigh Ann Black, Megan M Kibbey, Melissa A Tingler, Terry A Day

Cancer Lett· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion.
Mark G Slomiany, Steven A Rosenzweig

J Pharmacol Exp Ther· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma.
Mark G Slomiany, Leigh Ann Black, Megan M Kibbey, Terry A Day, Steven A Rosenzweig

Biochem Biophys Res Commun· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autocrine effects of IGF-I-induced VEGF and IGFBP-3 secretion in retinal pigment epithelial cell line ARPE-19.
Mark G Slomiany, Steven A Rosenzweig

Am J Physiol Cell Physiol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IGF-1-induced VEGF and IGFBP-3 secretion correlates with increased HIF-1 alpha expression and activity in retinal pigment epithelial cell line D407.
Mark G Slomiany, Steven A Rosenzweig

Invest Ophthalmol Vis Sci· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis